Immediate Impact

1 by Nobel laureates 65 standout
Sub-graph 1 of 21

Citing Papers

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
2024 Standout
2 intermediate papers

Works of Dirk Waldschmidt being referenced

Conko-006: a Randomized Double-Blinded Phase Iib-Study of Adjuvant Therapy with Gemcitabine + Sorafenib/Placebo for Patients with R1-Resection of Pancreatic Cancer
2014
A phase 2 study of a novel transforming growth factor-beta (TGF-β1) receptor I kinase inhibitor, LY2157299 monohydrate (LY), in patients with advanced hepatocellular carcinoma (HCC).
2014

Author Peers

Author Last Decade Papers Cites
Dirk Waldschmidt 586 257 179 204 65 889
Kristen Spencer 474 268 133 178 56 850
Michael Doukas 398 287 81 361 64 1.1k
Lakshmi Rajdev 585 298 148 291 64 1.0k
M. Henar Alonso 354 215 144 390 42 996
Hwajeong Lee 398 300 147 563 92 1.1k
Roberta Cerutti 338 148 190 166 58 959
Raphael Mohr 289 219 125 159 69 884
Giorgio Frega 450 225 135 375 54 835
Jennifer Ma 309 164 183 176 51 790
Feng Luo 455 163 156 128 57 894

All Works

Loading papers...

Rankless by CCL
2026